WIPOProtect this trademark from copycats!
With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.
The International trademark MYOLIVITY was filed as Word mark on 11/19/2021 at the World Intellectual Property Organization.
| Trademark form | Word mark |
| File reference | 1634378 |
| Countries | 
|
| Base trademark |
No. 90726719,
May 21, 2021
|
| Application date | November 19, 2021 |
| Expiration date | November 19, 2031 |
Trademark owner
215 First Street
Cambridge MA 02142
US
Cambridge MA 02142
US
Trademark representatives
Tepper & Eyster, PLLC,
3724 Benson Drive
US
goods and services
05
Pharmaceutical preparations for the treatment of
neuromuscular diseases and disorders, muscular dystrophies,
central nervous system diseases and disorders, genetic
diseases and disorders; pharmaceutical preparations based on
morpholino oligomer technology platform for the treatment of
neuromuscular diseases and disorders, muscular dystrophies,
central nervous system diseases and disorders, genetic
diseases and disorders, and for the regulation of protein
production; pharmaceutical preparations that modulate RNA
expression for the treatment of neuromuscular diseases and
disorders, muscular dystrophies, central nervous system
diseases and disorders, genetic diseases and disorders, and
for the regulation of protein production; gene therapy
products, namely, gene delivery pharmaceuticals;
pharmaceutical preparations for gene therapy, gene editing,
and genome editing; gene therapy products for the treatment
of neuromuscular diseases and disorders, muscular
dystrophies, central nervous system diseases and disorders,
genetic diseases and disorders; biological preparations for
the treatment of neuromuscular diseases and disorders,
muscular dystrophies, central nervous system diseases and
disorders, genetic diseases and disorders; viruses, viral
vectors and viral constructs for the treatment of
neuromuscular diseases and disorders, muscular dystrophies,
central nervous system diseases and disorders, genetic
diseases and disorders; pharmaceutical preparations,
biological preparations and gene therapy products in the
nature of pharmaceutical and biological preparations for the
treatment of genetic disorders and diseases
Trademark history
| Date | Document number | Area | Entry |
|---|---|---|---|
| July 4, 2023 | 2023/27 Gaz | IS | Rejection |
| April 19, 2023 | 2023/17 Gaz | BR | Rejection |
| April 14, 2023 | 2023/16 Gaz | CA | Rejection |
| February 6, 2023 | 2023/6 Gaz | KR | Rejection |
| January 3, 2023 | 2023/1 Gaz | CH | Rejection |
| October 25, 2022 | 2022/44 Gaz | IN | Rejection |
| September 29, 2022 | 2022/39 Gaz | JP | Rejection |
| September 23, 2022 | 2022/38 Gaz | MX | Rejection |
| May 20, 2022 | 2022/21 Gaz | EM | Rejection |
| May 17, 2022 | 2022/20 Gaz | TR | Rejection |
| April 19, 2022 | 2022/16 Gaz | CN | Rejection |
| April 11, 2022 | 2022/15 Gaz | RU | Rejection |
| March 22, 2022 | 2022/12 Gaz | AU | Rejection |
| February 3, 2022 | 2022/6 Gaz | US | Correction |
| November 19, 2021 | 2021/49 Gaz | US | Registration |
ID: 141634378